BBLG

Bone Biologics Corp BBLG

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 4 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$435.8K total
CITADEL ADVISORS LLC
$428.7K+69.0%
UBS Group AG
$4.1K+7.3%
Tower Research Capital LLC (TRC)
$2.7K-52.7%
SBI Securities Co., Ltd.
$3150.0%
See all 4 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/BBLG

Earnings Per Share

13fpro.ai/company/BBLG

Loading ratio trend…

BBLG key financials by period

Reported revenue, net income and operating margin by fiscal year, from Bone Biologics Corp's annual filings on SEC EDGAR.

Bone Biologics Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2020$1.1B$-1.8M-0.1%
FY 2019$1.1B$-3.4M-0.2%
FY 2016$1.1B$-25.9M-1.9%
Source: BBLG filings on SEC EDGAR →

BBLG insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Bone Biologics Corp (BBLG): stock profile, AI score and financials

Bone Biologics Corp (BBLG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BBLG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 4 institutional filers currently hold this stock. Top institutional holders of BBLG by reported 13-F value include CITADEL ADVISORS, UBS Group AG, Tower Research Capital (TRC), based on the most recent SEC filings. BBLG trades on the Nasdaq exchange and files with the SEC under CIK 1419554. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BBLG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bone Biologics Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1419554 →